These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4921094)

  • 21. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
    Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
    Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
    Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rodent malaria: BCG-induced protection and immunosuppression.
    Smrkovski LL; Strickland GT
    J Immunol; 1978 Oct; 121(4):1257-61. PubMed ID: 100553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
    Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research.
    Chege GK; Williamson AL; Passmore JS; Bourn W; Ryffel B; Shephard EG
    Vaccine; 2005 Dec; 23(50):5783-91. PubMed ID: 16214269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.
    Wu B; Huang C; Garcia L; Ponce de Leon A; Osornio JS; Bobadilla-del-Valle M; Ferreira L; Canizales S; Small P; Kato-Maeda M; Krensky AM; Clayberger C
    Infect Immun; 2007 Jul; 75(7):3658-64. PubMed ID: 17502394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.
    Cai H; Yu DH; Hu XD; Li SX; Zhu YX
    DNA Cell Biol; 2006 Aug; 25(8):438-47. PubMed ID: 16907641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection.
    Ryan AA; Spratt JM; Britton WJ; Triccas JA
    Infect Immun; 2007 Jan; 75(1):523-6. PubMed ID: 17074853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective response in guinea pigs exposed to Mycobacterium aviumintracellulare/M. scrofulaceum, BCG & south Indian isolates of M. tuberculosis.
    Herbert D; Paramasivan CN; Prabhakar R
    Indian J Med Res; 1994 Jan; 99():1-7. PubMed ID: 8163294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis bacillus Calmette Guerín.
    Palmer MV; Thacker TC; Waters WR
    Vaccine; 2007 Sep; 25(36):6589-97. PubMed ID: 17688976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.